COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 573: Articles 5721-5730  | Next

Genomic tracking of SARS-COV-2 variants in Myanmar
Oo, K. Z., Htun, Z. W., Aung, N. M., Win, K. K., Htoo, S. P., Oo, T. W., Linn, K. Z., Aung, P. K., Zaw, M. T., Tun, K. M., Myint, K., Lwin, K. K.
10.1101/2022.10.10.511623 — Posted: 2022-10-11
GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics.
Zvyagin, M. T., Brace, A., Hippe, K., Deng, Y., Zhang, B., Orozco Bohorquez, C., Clyde, A., Kale, B., Perez-Rivera, D., Ma, H., Mann, C. M., Irvin, M., Pauloski, J. G., Ward, L., Hayot, V., Emani, M., Foreman, S., Xie, Z., Lin, D., Shukla, M., Nie, W., Romero, J., Dallago, C., Vahdat, A., Xiao, C., Gibbs, T., Foster, I., Davis, J. J., Papka, M. E., Brettin, T., Anandkumar, A., Vishwanath, V., Ramanathan, A.
10.1101/2022.10.10.511571 — Posted: 2022-10-11
Psychophysiologic symptom relief therapy (PSRT) for post-acute sequelae of COVID-19: a non-randomized interventional study
Donnino, M. W., Howard, P., Mehta, S., Silverman, J., Cabrera, M. J., Yamin, J. B., Balaji, L., Tolin, R., Berg, K. M., Edwards, R., Grossestreuer, A. V.
10.1101/2022.10.07.22280732 — Posted: 2022-10-10
Gut microbial disruption in critically ill patients with COVID-19 associated pulmonary aspergillosis
Schult, D., Maurer, C., Koyumdzhieva, P., Reitmeier, S., Middelhoff, M., Rasch, S., List, M., Janssen, K.-P., Steiger, K., Protzer, U., Schmid, R. M., Neuhaus, K., Haller, D., Quante, M., Lahmer, T.
10.1101/2022.10.08.511408 — Posted: 2022-10-10
Incidence, risk and severity of SARS-CoV-2 reinfections in children and adolescents: a population-level study between March 2020 and July 2022
Medic, S., Anastassopoulou, C., Lozanov-Crvenkovic, Z., Dragnic, N., Petrovic, V., Ristic, M., Pustahija, T., Tsakris, A., Ioannidis, J.
10.1101/2022.10.09.22280690 — Posted: 2022-10-10
Health care workers self-perceived infection risk and COVID-19 vaccine uptake: a mixed methods study
Nyamuryekung'e, K. K., Amour, M., Mboya, I., Ndumwa, H., Kengia, J., Njiro, B., Mhamilawa, L., Shayo, E., Ngalesoni, F., Kapologwe, N., Kalolo, A., Metta, E., Msuya, S.
10.1101/2022.10.07.22280829 — Posted: 2022-10-10
Time trends of mental health indicators in Germany's adult population before and during the COVID-19 pandemic
Mauz, E., Walther, L., Junker, S., Kersjes, C., Damerow, S., Eicher, S., Hölling, H., Müters, S., Peitz, D., Schnitzer, S., Thom, J.
10.1101/2022.10.09.22280826 — Posted: 2022-10-10
GRAd-COV2 vaccine provides potent and durable immunity in a randomised placebo-controlled phase 2 trial (COVITAR)
Capone, S., Fusco, F. M., Milleri, S., Borre', S., Carbonara, S., Lo Caputo, S., Leone, S., Gori, G., Maggi, P., Cascio, A., Lichtner, M., Cauda, R., Dal Zoppo, S., Cossu, M. V., Gori, A., Roda, S., Confalonieri, P., Bonora, S., Missale, G., Codeluppi, M., Mezzaroma, I., Capici, S., Pontali, E., Libanore, M., Diani, A., Lanini, S., Battella, S., Contino, A. M., Piano Mortari, E., Genova, F., Parente, G., Dragonetti, R., Colloca, S., Visani, L., Iannacone, C., Carsetti, R., Folgori, A., Camerini, R., the COVITAR study group
10.1101/2022.10.08.22280836 — Posted: 2022-10-10
Immune response after SARS-CoV-2 infection with residual post COVID symptoms
Pongkunakorn, T., Manosan, T., Surawit, A., Ophakas, S., Mongkolsucharitkul, P., Pumiem, S., Suta, S., Pinsawas, B., Sookrung, N., Saelim, N., Mahasongkram, K., Prangtaworn, P., Tungtrongchitr, A., Tangjittipokin, W., Boonnak, K., Narkdontri, T., Teerawattanapong, N., Jongkaewwattana, A., Mayurasakorn, K.
10.1101/2022.10.10.22280762 — Posted: 2022-10-10
Impact of the COVID-19 Vaccination Program on Case Incidence, Emergency Department Visits, and Hospital Admissions among Children Aged 5-17 Years during the Delta and Omicron Periods --United States, December 2020 to April 2022
Topf, K., Sheppard, M., Marx, G., Wiegand, R., Link-Gelles, R., Binder, A., Cool, A., Lyons, B. C., Park, S., Fast, H., Presnetsov, A., Azondekon, G. R., Soetebier, K., Adjemian, J., Barbour, K. E.
10.1101/2022.10.07.22280822 — Posted: 2022-10-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).